Total Payments
$2,430
2024 Payments
$733.64
Companies
16
Transactions
30
Payment Breakdown by Category
Consulting$1,863 (76.6%)
Food & Beverage$563.85 (23.2%)
Education$3.67 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,863 | 5 | 76.6% |
| Food and Beverage | $563.85 | 20 | 23.2% |
| Education | $3.67 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Marinus Pharmaceuticals, Inc. | $866.67 | 2 | $0 (2023) |
| Shionogi Inc | $580.00 | 1 | $0 (2024) |
| TerSera Therapeutics LLC | $398.00 | 1 | $0 (2022) |
| BioMarin Pharmaceutical Inc. | $153.64 | 1 | $0 (2024) |
| SK Life Science, Inc. | $91.93 | 3 | $0 (2021) |
| AQUESTIVE THERAPEUTICS, INC. | $69.19 | 4 | $0 (2021) |
| UCB, Inc. | $60.39 | 2 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $52.94 | 3 | $0 (2020) |
| Neurelis, Inc. | $35.77 | 2 | $0 (2020) |
| PTC Therapeutics, Inc. | $31.66 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $733.64 | 2 | Shionogi Inc ($580.00) |
| 2023 | $284.76 | 2 | Marinus Pharmaceuticals, Inc. ($260.00) |
| 2022 | $1,069 | 6 | Marinus Pharmaceuticals, Inc. ($606.67) |
| 2021 | $136.33 | 9 | SK Life Science, Inc. ($66.39) |
| 2020 | $129.73 | 7 | Neurelis, Inc. ($35.77) |
| 2019 | $57.07 | 3 | Sunovion Pharmaceuticals Inc. ($22.53) |
| 2018 | $19.28 | 1 | Sunovion Pharmaceuticals Inc. ($19.28) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | BioMarin Pharmaceutical Inc. | Brineura (Drug) | Food and Beverage | In-kind items and services | $153.64 | General |
| Category: CLN 2 | ||||||
| 04/05/2024 | Shionogi Inc | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 06/14/2023 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: RETT SYNDROME | ||||||
| 05/03/2023 | Marinus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $260.00 | General |
| 12/14/2022 | Marinus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $606.67 | General |
| 11/21/2022 | Amneal Pharmaceuticals LLC | — | Consulting Fee | Cash or cash equivalent | $18.00 | General |
| 08/26/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 08/25/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 06/21/2022 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $45.05 | General |
| Category: Neurology | ||||||
| 05/20/2022 | TerSera Therapeutics LLC | — | Consulting Fee | Cash or cash equivalent | $398.00 | General |
| 10/29/2021 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 10/29/2021 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.35 | General |
| Category: Hepatology | ||||||
| 10/19/2021 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 05/25/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 04/28/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.57 | General |
| 04/09/2021 | AQUESTIVE THERAPEUTICS, INC. | SYMPAZAN (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Neurology | ||||||
| 03/12/2021 | AQUESTIVE THERAPEUTICS, INC. | SYMPAZAN (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Neurology | ||||||
| 01/22/2021 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $49.82 | General |
| Category: Neurology | ||||||
| 01/08/2021 | AQUESTIVE THERAPEUTICS, INC. | SYMPAZAN (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Neurology | ||||||
| 11/20/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/13/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Immunology | ||||||
| 11/09/2020 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: EPILEPSY | ||||||
| 10/15/2020 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.54 | General |
| 08/06/2020 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: EPILEPSY | ||||||
| 03/02/2020 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: DMD | ||||||
About Dr. Sailaja Golla, MD
Dr. Sailaja Golla, MD is a Neurodevelopmental Disabilities healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1033309836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sailaja Golla, MD has received a total of $2,430 in payments from pharmaceutical and medical device companies, with $733.64 received in 2024. These payments were reported across 30 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($1,863).
Ad
Practice Information
- Specialty Neurodevelopmental Disabilities
- Other Specialties Neurology with Special Qualifications in Child Neurology, Neurology with Special Qualifications in Child Neurology
- Location Orange, CA
- Active Since 07/27/2007
- Last Updated 08/10/2021
- Taxonomy Code 2084P0005X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033309836
Products in Payments
- Brineura (Drug) $153.64
- SYMPAZAN (Drug) $69.19
- APTIOM (Drug) $52.94
- XCOPRI (Drug) $49.82
- Nayzilam (Drug) $45.05
- VALTOCO (Drug) $35.77
- EMFLAZA (Drug) $31.66
- DAYBUE (Drug) $24.76
- ADHANSIA XR (Drug) $17.94
- Briviact (Drug) $15.34
- Soliris (Drug) $13.68
- NUEDEXTA (Drug) $11.95
- Cholbam (Drug) $3.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurodevelopmental Disabilities Doctors in Orange
Anne E Tournay, Md, MD
Neurodevelopmental Disabilities — Payments: $462.18
Neurodevelopmental Disabilities $462.18
Naser Elbalalesy, Md, MD
Neurodevelopmental Disabilities — Payments: $334.04
Neurodevelopmental Disabilities $334.04
Tallie Z Baram, Md, MD
Neurodevelopmental Disabilities — Payments: $33.56
Neurodevelopmental Disabilities $33.56
Ira Lott, Md, MD
Neurodevelopmental Disabilities — Payments: $18.68
Neurodevelopmental Disabilities $18.68
Dr. Emily Garavatti, Md, MD
Neurodevelopmental Disabilities
Neurodevelopmental Disabilities